Prostate cancer decisions — 2023
955 indexed Board decisions in 2023.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedMarch 2023
The Board has granted service connection for the Veteran's residuals of prostate cancer, including incontinence, based on presumed exposure to herbicide agents during his service at Udorn RTAFB in Thailand.
- Whole decision: Remanded (sent back)March 2023
The Board has remanded the case due to issues related to increased ratings for prostate cancer and a claim for TDIU. The specific issues include determining if the Veteran meets criteria for higher ratings based on voiding dysfunction and renal dysfunction, as well as considering his eligibility for TDIU.
- Whole decision: Remanded (sent back)PACT Act · March 2023
The Board has remanded the case due to insufficient evidence regarding whether the Veteran is a 'covered veteran' under the PACT Act and for further development of his service connection claims, including obtaining an opinion on the etiology and pathophysiology of his prostate cancer.
- Whole decision: DismissedMarch 2023
The Veteran's appeal for reducing his prostate cancer disability rating from 100 percent to 40 percent has been dismissed because the Veteran requested a withdrawal of his appeal.
- Whole decision: DeniedMarch 2023
The Veteran's appeal to restore a 100 percent disability rating for prostate cancer was denied as the evidence did not support his claim that he remained cancer-free.
- Whole decision: GrantedPACT Act · March 2023
The Veteran's claim for service connection for hypertension due to herbicide agent exposure is granted. The other issues are remanded and will be reconsidered based on the new evidence.
- Whole decision: GrantedMarch 2023
The Veteran's service connection claims for coronary artery disease, prostate cancer, and erectile dysfunction due to herbicide exposure are granted. The claim for a kidney disorder is remanded.
- Whole decision: Remanded (sent back)March 2023
The Board has remanded the issues of service connection for diabetes mellitus type II, prostate cancer, peripheral neuropathy of the left lower extremity, and peripheral neuropathy of the right lower extremity due to claimed herbicide exposure. The remand requires verification of in-service DDT exposure and obtaining medical opinions regarding the relationship between these conditions and service.
- Whole decision: Remanded (sent back)March 2023
The Board has remanded the cases due to incomplete VA examinations and outstanding treatment records. The Veteran's prostate cancer and erectile dysfunction claims are being reviewed again.
- Whole decision: DeniedMarch 2023
The Veteran's prostate and squamous cell carcinoma were not found to be related to his military service, including exposure to herbicide agents. Service connection was denied for both conditions.
- Whole decision: GrantedPACT Act · March 2023
The Veteran's service connection for prostate cancer, status post prostatectomy, is granted. The issue of entitlement to a temporary total disability rating for convalescence following surgery for a service-connected disability is remanded.
- Whole decision: DeniedMarch 2023
The Board denied the Veteran's claim for service connection for prostate cancer, finding that there was no evidence of herbicide exposure during his service in Okinawa and thus failing to meet the requirements for presumptive service connection under 38 C.F.R. § 3.309(e).
- Whole decision: DismissedMarch 2023
The Veteran withdrew his appeal for service connection for prostate cancer claimed as the result of herbicide agent exposure, and the Board dismissed the appeal.
- Whole decision: DismissedMarch 2023
The Veteran withdrew his appeals for prostate cancer, voiding dysfunction, and erectile dysfunction.
- Whole decision: Remanded (sent back)March 2023
The Board has remanded the issues of entitlement to an increased rating for prostate cancer residuals and service connection for peripheral neuropathy of the bilateral lower extremities due to potential new evidence or further examination.
- Whole decision: GrantedMarch 2023
The Veteran's bilateral hearing loss and tinnitus are granted as service connection is established due to in-service noise exposure.,Prostate cancer, diabetes mellitus type 2, and decreased vision in the left eye are remanded for further development.
- Whole decision: GrantedMarch 2023
The Veteran's PTSD is rated as 100 percent disabling, and he has a combined service-connected rating of at least 60 percent for other disabilities. The Board granted an initial 100 percent schedular rating for PTSD and special monthly compensation at the housebound rate from November 2, 2016, to December 21, 2020.
- Whole decision: DeniedMarch 2023
The Veteran's bilateral orchiectomy and prostate cancer have resulted in a 30 percent evaluation, with no higher.,Prostate cancer has been rated at 40 percent from January 28, 2016, to July 26, 2016.
- Whole decision: GrantedMarch 2023
The Veteran's service-connected disabilities rendered him unemployable as of October 30, 2013. The Board granted a total disability rating based on individual unemployability (TDIU) effective from that date.
- Whole decision: Remanded (sent back)PACT Act · March 2023
The Veteran's claim for service connection for prostate cancer due to herbicide exposure is granted.,The Veteran's claims for increased ratings for PTSD, bilateral upper extremity neurological disorders (likely carpal tunnel syndrome), and a disorder manifested by dizziness are remanded for further development.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.